🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Estimated number of participants: 342 participants with COVID-19 Design: Ph...
Status
Completed
Location
Santa Casa de Misericordia de Campos
Start Date
2021-04-23
Trial ID
NCT04668235
Treatments Being Tested
A Phase II Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate t...
Status
Unknown
Location
Huashan Hospital
Start Date
2023-01-06
Trial ID
NCT05682599
To investigate whether treatment with Azvudine reduces the risk of severe i...
Status
Recruiting
Location
Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital
Start Date
2023-04-19
Trial ID
NCT05689034
A Phase II/III Randomized, Double-Blind, Placebo-Controlled Trial to Evalua...
Status
Unknown
Location
University of Malaya Medical Centre
Start Date
2022-12-29
Trial ID
NCT05633433
Azvudine,(FNC)， new nuclear nucleoside reverse transcriptase inhibitors, FN...
Status
Unknown
Location
Beijing YouAn Hospital, Capital Medical University
Start Date
2020-04-01
Trial ID
NCT04303598
Treatments Being Tested
Through regular monitoring of viral load, liver function and immune cell ac...
Status
Recruiting
Location
The First Affiliated Hospital of Zhengzhou University
Start Date
2025-09-01
Trial ID
NCT07307586
Azvudine(FNC)，a nucleoside reverse transcriptase inhibitor, make itself a b...
Status
Completed
Location
Heping Hospital Affliliated to Changzhi Medical College
Start Date
2021-12-20
Trial ID
NCT07002255
Azvudine(FNC)，a nucleoside reverse transcriptase inhibitor, make itself a b...
Status
Completed
Location
Phase I Clinical Trial Research Center of Dongguan Kanghua Hospital
Start Date
2022-02-21
Trial ID
NCT07001501
The purpose of this study is to explore the factors that can affect the dev...
Status
Unknown
Location
The Fifth Affiliated Hospital of Sun Yat-sen University
Start Date
2023-08-05
Trial ID
NCT06006611
Treatments Being Tested
Azvudine(FNC)，a nucleoside reverse transcriptase inhibitor, make itself a b...
Status
Completed
Location
Tianjin People's Hospital
Start Date
2022-07-06
Trial ID
NCT07002242
Treatments Being Tested